VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,867,202 | +4.6% | 1,589,630 | +59.5% | 0.00% | 0.0% |
| Q2 2023 | $6,567,878 | -22.6% | 996,643 | -20.2% | 0.00% | 0.0% |
| Q1 2023 | $8,484,824 | +46.5% | 1,249,606 | +59.4% | 0.00% | 0.0% |
| Q4 2022 | $5,793,398 | +19.9% | 783,951 | +60.2% | 0.00% | 0.0% |
| Q3 2022 | $4,833,000 | -34.2% | 489,273 | -27.4% | 0.00% | 0.0% |
| Q2 2022 | $7,347,000 | +57.3% | 674,038 | +63.2% | 0.00% | 0.0% |
| Q1 2022 | $4,670,000 | +2.9% | 412,977 | +42.7% | 0.00% | 0.0% |
| Q4 2021 | $4,540,000 | +6.9% | 289,389 | +16.8% | 0.00% | 0.0% |
| Q3 2021 | $4,247,000 | -57.2% | 247,741 | -46.3% | 0.00% | 0.0% |
| Q2 2021 | $9,928,000 | +147.9% | 461,535 | +73.1% | 0.00% | 0.0% |
| Q1 2021 | $4,005,000 | -66.0% | 266,588 | -70.3% | 0.00% | -50.0% |
| Q4 2020 | $11,785,000 | +327.1% | 896,863 | +214.1% | 0.00% | +100.0% |
| Q3 2020 | $2,759,000 | +17.2% | 285,550 | +38.7% | 0.00% | 0.0% |
| Q2 2020 | $2,354,000 | -61.2% | 205,828 | -64.8% | 0.00% | -50.0% |
| Q1 2020 | $6,060,000 | -38.8% | 584,972 | -3.0% | 0.00% | 0.0% |
| Q4 2019 | $9,897,000 | +42.1% | 603,059 | +15.0% | 0.00% | 0.0% |
| Q3 2019 | $6,965,000 | -18.6% | 524,569 | -13.6% | 0.00% | 0.0% |
| Q2 2019 | $8,554,000 | -25.9% | 607,086 | -3.2% | 0.00% | -33.3% |
| Q1 2019 | $11,542,000 | -33.2% | 627,232 | -5.1% | 0.00% | -40.0% |
| Q4 2018 | $17,277,000 | +44.7% | 661,233 | +27.1% | 0.01% | +66.7% |
| Q3 2018 | $11,942,000 | -45.5% | 520,349 | -54.7% | 0.00% | -50.0% |
| Q2 2018 | $21,903,000 | +5.4% | 1,149,710 | -6.8% | 0.01% | 0.0% |
| Q1 2018 | $20,781,000 | +30.7% | 1,233,256 | +17.9% | 0.01% | +50.0% |
| Q4 2017 | $15,897,000 | -18.1% | 1,045,843 | -3.6% | 0.00% | -33.3% |
| Q3 2017 | $19,416,000 | +0.6% | 1,084,722 | -8.4% | 0.01% | 0.0% |
| Q2 2017 | $19,305,000 | -56.8% | 1,184,333 | -62.9% | 0.01% | -14.3% |
| Q1 2017 | $44,646,000 | -21.7% | 3,188,992 | -10.7% | 0.01% | -22.2% |
| Q4 2016 | $56,992,000 | +86.0% | 3,573,080 | +94.0% | 0.01% | -10.0% |
| Q3 2016 | $30,645,000 | +44.5% | 1,841,634 | -2.8% | 0.01% | +25.0% |
| Q2 2016 | $21,209,000 | +79.4% | 1,895,315 | +34.1% | 0.01% | +60.0% |
| Q1 2016 | $11,819,000 | -11.6% | 1,413,809 | -1.6% | 0.01% | 0.0% |
| Q4 2015 | $13,376,000 | -24.6% | 1,436,808 | -8.7% | 0.01% | -28.6% |
| Q3 2015 | $17,742,000 | -4.1% | 1,572,900 | +7.9% | 0.01% | +16.7% |
| Q2 2015 | $18,495,000 | +39.9% | 1,457,511 | +2.6% | 0.01% | +20.0% |
| Q1 2015 | $13,217,000 | -36.7% | 1,421,114 | -2.5% | 0.01% | -37.5% |
| Q4 2014 | $20,874,000 | +175.9% | 1,457,718 | +100.0% | 0.01% | +166.7% |
| Q3 2014 | $7,565,000 | -32.4% | 728,806 | +5.4% | 0.00% | -25.0% |
| Q2 2014 | $11,189,000 | +86.6% | 691,527 | +87.4% | 0.00% | +33.3% |
| Q1 2014 | $5,996,000 | +49.4% | 368,973 | +14.1% | 0.00% | +50.0% |
| Q4 2013 | $4,013,000 | +122.9% | 323,408 | +96.8% | 0.00% | +100.0% |
| Q3 2013 | $1,800,000 | +620.0% | 164,335 | +432.8% | 0.00% | – |
| Q2 2013 | $250,000 | – | 30,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |